Rat IgG (F(ab)2 Fragment) Fc specific Goat Polyclonal Antibody
CAT#: R1414AP
Rat IgG (F(ab)2 Fragment) Fc specific goat polyclonal antibody, AP
Need it in bulk or conjugated?
Get a free quote
CNY 4,988.00
货期*
4周
规格
Cited in 1 publication. |
Product images
Specifications
Product Data | |
Product Name | Rat IgG (F(ab)2 Fragment) Fc specific Goat Polyclonal Antibody |
Recommend Dilution | Suitable for Immunoblotting (Western or dot blot), ELISA and Immunohistochemistry as well as other phosphatase-antibody based enzymatic assays requiring extremely low background levels, absence of F(c) mediated binding, lot-to-lot consistency, high titer and specificity. Recommended Dilution(s): This product has been assayed against 1.0 ug of Rat IgG in a standard capture ELISA using pNPP p-nitrophenyl phosphate as a substrate for 30 minutes at room temperature. A working dilution of 1:1,000 to 1:5,000 of the reconstitution concentration is suggested for this product. |
Reactivity | Rat |
Host | Goat |
Immunogen | Rat IgG F(c) fragment |
Formulation | 0.05 M Tris Chloride, 0.15 M Sodium Chloride, 0.001 M Magnesium Chloride, 0.0001 M Zinc Chloride, 50% (v/v) Glycerol; pH 8.0 with 10 mg/ml Bovine Serum Albumin (BSA, IgG and Protease free) as stabilizer and 0.01% (w/v) Sodium Azide as preservative. Label: AP State: Liquid (sterile filtered) F(ab')2 fragments. Label: Alkaline Phosphatase (Calf Intestine) (Molecular Weight 140,000 daltons) |
Concentration | lot specific |
Purification | Immunoaffinity chromatography. |
Conjugation | AP |
Storage Condition | The antibody is stable at 2-8°C as undiluted liquid. DO NOT FREEZE! Freezing alkaline phosphatase conjugates will result in a substantial loss of enzymatic activity. Dilute only prior to immediate use. |
Citations (1)
The use of this Antibodies has been cited in the following citations: |
---|
MyD88 Mediates Colitis- and RANKL-Induced Microfold Cell Differentiation
,null,
Veterinary Sciences
,PubMed ID 35051090
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Customer
Reviews
Loading...